LILIA AVILA: Open Payments
NPI 1063993731 · ROCKFORD, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$494 in 24 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $276 · 2025 $494
Food & beverage: $494
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 6 | $127 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $86 |
| Olympus America Inc. | 4 | $73 |
| ABBVIE INC. | 3 | $50 |
| Dendreon Pharmaceuticals LLC | 1 | $29 |
| Sumitomo Pharma America, Inc. | 1 | $26 |
| Merck Sharp & Dohme LLC | 1 | $25 |
| UROGEN PHARMA, INC. | 1 | $23 |
| PROGENICS PHARMACEUTICALS, INC. | 1 | $23 |
| Tempus AI, Inc | 1 | $16 |
Products named: ERLEADA, Nubeqa, iTIND System, LUPRON DEPOT, PROVENGE, GEMTESA, KEYTRUDA, JELMYTO.
Industry payments across IL — which companies pay providers there.
